Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven W Lane

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
Cancer Cell|June 15, 2010
Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cellsAnn Mullally, Steven W Lane, Brian Ball, et al.
Blood|March 15, 2013
Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-α in a murine model of polycythemia veraAnn Mullally, Claudia Bruedigam, Luke Poveromo, et al.
The Journal of Clinical Investigation|May 15, 2018
CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanismsXian-Yang Li, Indrajit Das, Ailin Lepletier, et al.
Leukemia|November 18, 2022
Targeting cell cycle and apoptosis to overcome chemotherapy resistance in acute myeloid leukemiaVictoria Y Ling, Jasmin Straube, William Godfrey, et al.
Leukemia|August 16, 2023
Cell fate determinant Llgl1 is required for propagation of acute myeloid leukemiaTheresa Eifert, Chen-Jen Hsu, Alicia L Becker, et al.
Cell Stem Cell|December 7, 2014
Telomerase inhibition effectively targets mouse and human AML stem cells and delays relapse following chemotherapyClaudia Bruedigam, Frederik O Bagger, Florian H Heidel, et al.
Nature Medicine|July 10, 2010
Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemiaMichael G Kharas, Christopher J Lengner, Fatima Al-Shahrour, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 2013
Induced regulatory T cells promote tolerance when stabilized by rapamycin and IL-2 in vivoPing Zhang, Siok-Keen Tey, Motoko Koyama, et al.
Nature Communications|April 14, 2023
Oncogenic drivers dictate immune control of acute myeloid leukemiaRebecca J Austin, Jasmin Straube, Rohit Halder, et al.
Blood Advances|January 28, 2025
ALLG APML5: bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APLHarry J Iland, John Reynolds, Alan V Boddy, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Cancer Cell|June 15, 2010
Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cellsAnn Mullally, Steven W Lane, Brian Ball, et al.
Blood|March 15, 2013
Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-α in a murine model of polycythemia veraAnn Mullally, Claudia Bruedigam, Luke Poveromo, et al.
The Journal of Clinical Investigation|May 15, 2018
CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanismsXian-Yang Li, Indrajit Das, Ailin Lepletier, et al.
Leukemia|November 18, 2022
Targeting cell cycle and apoptosis to overcome chemotherapy resistance in acute myeloid leukemiaVictoria Y Ling, Jasmin Straube, William Godfrey, et al.
Leukemia|August 16, 2023
Cell fate determinant Llgl1 is required for propagation of acute myeloid leukemiaTheresa Eifert, Chen-Jen Hsu, Alicia L Becker, et al.
Cell Stem Cell|December 7, 2014
Telomerase inhibition effectively targets mouse and human AML stem cells and delays relapse following chemotherapyClaudia Bruedigam, Frederik O Bagger, Florian H Heidel, et al.
Nature Medicine|July 10, 2010
Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemiaMichael G Kharas, Christopher J Lengner, Fatima Al-Shahrour, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 2013
Induced regulatory T cells promote tolerance when stabilized by rapamycin and IL-2 in vivoPing Zhang, Siok-Keen Tey, Motoko Koyama, et al.
Nature Communications|April 14, 2023
Oncogenic drivers dictate immune control of acute myeloid leukemiaRebecca J Austin, Jasmin Straube, Rohit Halder, et al.
Blood Advances|January 28, 2025
ALLG APML5: bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APLHarry J Iland, John Reynolds, Alan V Boddy, et al.
Pageof 11